Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-314435
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 2
---
 cash, without interest, subject to withholding of taxes (the “Merger Consideration”). Prior to the entry into the Second Amendment, holders of STAAR common stock as of the date and time the Merger is effective (other
than certain excluded shares as described in the Merger Agreement) would have received merger consideration of $28.00 per share in cash, without interest, subject to withholding of taxes.

The STAAR Board of Directors approved the Second Amendment after careful consideration and deliberation and determined that the Merger
Agreement and the transactions contemplated thereby, as amended by the Amendments, including the Merger, are advisable, fair to and in the best interests of STAAR and its stockholders, approved, adopted and declared advisable the execution and
delivery of, and entry into, the Second Amendment, and directed that the Merger Agreement be submitted to the STAAR stockholders for adoption at the special meeting of STAAR stockholders (including any adjournments or postponements thereof, the
“Special Meeting”).

2

The Merger cannot be completed without approval of the proposal to adopt the Merger Agreement by the affirmative vote of holders of a majority of the outstanding shares of STAAR common stock entitled to vote thereon. Because of this, STAAR is holding the Special Meeting for the following purposes:

| 1. | To consider and vote on the proposal to adopt the Merger Agreement, by and among STAAR, Alcon and Merger Sub 
 (the “Merger Proposal”); and                                                                                 |

| 2. | To consider and vote on the proposal to approve, on an advisory (nonbinding) basis, the compensation that may                                                                                                        
 be paid or become payable to STAAR’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement (the “Compensation Proposal”). |

The Special Meeting is scheduled for December 19, 2025 at 8:30 a.m., Pacific Time. The chair of the Special Meeting may, in his or her discretion, adjourn the Special Meeting to a later date or date(s), including for the purpose of soliciting additional proxies. The record date for the Special Meeting is the close of business on October 24, 2025 (the “Record Date”). Stockholders who hold shares as of the Record Date will be eligible to vote at the Special Meeting on December 19, 2025. The Special Meeting will be held in a virtual meeting format only. Stockholders who